NCT00692510 - Drug Interaction Study Between AZD3480 and Cytochrome P450 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions

MetabolismAlzheimer's Disease

Interventions

DRUG

AZD3480

Capsule, oral, dose once daily, 7 days

DRUG

Placebo

Capsule, oral, dose once daily, 7 days

DRUG

Cocktail mix (Caffeine, Bupropion, Rosiglitazone, Omeprazole, Midazolam, Bilirubin)

"Cocktail mix which contains the following:~CYP1A2 (Caffeine), CYP2B6 (Bupropion), CYP2C8 (Rosiglitazone), CYP2C19 (Omeprazole), CYP3A4 (Midazolam), UGT1A1 (Bilirubin)~single dose of mix"

Trial Locations (1)

Unknown

Research Site, Uppsala